82 related articles for article (PubMed ID: 6468181)
21. Breast cancer in the elderly patient: early detection with mammography.
Wilson TE; Helvie MA; August DA
Radiology; 1994 Jan; 190(1):203-7. PubMed ID: 8259405
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions.
Bassett LW; Liu TH; Giuliano AE; Gold RH
AJR Am J Roentgenol; 1991 Jul; 157(1):21-4. PubMed ID: 1646562
[TBL] [Abstract][Full Text] [Related]
23. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
24. Steroid receptors in surgical pathology. With special reference to small mammographically detected breast lesions.
Ross JC; Binder S; Rounsaville MC; Lewin K
Pathology (Phila); 1992; 1(1):103-35. PubMed ID: 9420917
[TBL] [Abstract][Full Text] [Related]
25. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
26. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of the myogenic gene Myf-3 in human breast carcinomas.
Hähnel R; Harvey J; Kay P
Anticancer Res; 1996; 16(4A):2111-5. PubMed ID: 8712752
[TBL] [Abstract][Full Text] [Related]
28. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography.
Chang HR; Cole B; Bland KI
J Natl Cancer Inst Monogr; 1997; (22):145-9. PubMed ID: 9709291
[TBL] [Abstract][Full Text] [Related]
29. Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry.
Lee AK; Dugan J; Hamilton WM; Cook L; Heatley G; Kamat B; Silverman ML
Mod Pathol; 1991 Mar; 4(2):178-82. PubMed ID: 2047381
[TBL] [Abstract][Full Text] [Related]
30. Significance and staging of nonpalpable carcinomas of the breast.
Schwartz GF; Feig SA; Patchefsky AS
Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
[TBL] [Abstract][Full Text] [Related]
32. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
33. Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma.
Erhardt K; Auer G; Folin A; Silfverswärd C; Skoog L
Am J Clin Oncol; 1986 Feb; 9(1):83-9. PubMed ID: 3006475
[TBL] [Abstract][Full Text] [Related]
34. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
35. [Assay of DNA content and estrogen receptor status in human breast cancer].
Chen GJ; Shao YF; Shan Y
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
[TBL] [Abstract][Full Text] [Related]
36. Cytochemical classification of nonpalpable breast carcinoma.
Fallenius A; Svane G; Auer G; Caspersson TO
Anal Quant Cytol; 1983 Mar; 5(1):9-12. PubMed ID: 6303171
[TBL] [Abstract][Full Text] [Related]
37. Nonpalpable breast cancer.
Iino Y; Sugamata N; Aoyagi H; Takeo T; Takei H; Horiguchi J; Takai Y; Yokoe T; Ohwada S; Morishita Y
Anticancer Res; 1994; 14(5B):2193-5. PubMed ID: 7840522
[TBL] [Abstract][Full Text] [Related]
38. [Male breast cancer. Histochemical and flow cytometry analysis of 6 cases].
Galasso MG; Galia A; Gazzano G; Cosentino A; Castorina S
Pathologica; 1995 Oct; 87(5):503-5. PubMed ID: 8868175
[TBL] [Abstract][Full Text] [Related]
39. [Expression of oestrogen receptor-beta in invasive breast tumours].
Péter I; Számel I; Péley G
Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
[TBL] [Abstract][Full Text] [Related]
40. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
